Next 10 |
2024-05-20 16:47:47 ET Gainers: Maravai LifeSciences ( MRVI ) +5% . Caribou Biosciences ( CRBU ) +4% . Greenidge Generation Holdings ( GREE ) +4% . Cipher Mining ( CIFR ) +4% . SIGA Technologies ( SIGA ) +4%...
2024-05-15 09:56:00 ET Summary Mersana Therapeutics, Inc. is a cancer-focused biotech with two pipeline projects in phase 1 clinical study. Their lead compounds, XMT-1660 and XMT-2056, target novel immune checkpoints and HER2, respectively. The company has enough cash to suppo...
2024-05-09 14:09:08 ET Mersana Therapeutics, Inc. (MRSN) Q1 2024 Earnings Conference Call May 09, 2024 08:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations & Corporate Communications Martin Huber - President & Chief Exec...
2024-05-09 07:21:47 ET More on Mersana Therapeutics Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript Mersana Therapeutics Q1 2024 Earnings Preview Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M Seeking Al...
Maximum tolerated dose not yet established in Phase 1 clinical trial of XMT-1660; enrollment in dose escalation and backfill cohorts continuing in parallel; expect to announce initial clinical data and initiate expansion in the second half of 2024 Patient recruitment ongoing in Phase 1 cl...
2024-05-08 12:34:51 ET Major earnings expected before the bell on Thursday include: Medical Properties Trust ( MPW ) Plug Power ( PLUG ) Roblox ( RBLX ) Viatris ( VTRS ) Warner Bros. Discovery ( WBD ) Read the full article on Seeking Alpha ...
2024-05-08 11:45:14 ET More on Mersana Therapeutics Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M Mersana Therapeutics Q4 2023 Earnings Preview Seeking Al...
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that ...
2024-03-18 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-15 16:48:33 ET Gainers: 89bio ( ETNB ) +5% . Black Diamond Therapeutics ( BDTX ) +5% . Anavex Life Sciences ( AVXL ) +3% . iHeartMedia ( IHRT ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: CERo Th...
News, Short Squeeze, Breakout and More Instantly...
Mersana Therapeutics Inc. Company Name:
MRSN Stock Symbol:
NASDAQ Market:
Mersana Therapeutics Inc. Website:
Maximum tolerated dose not yet established in Phase 1 clinical trial of XMT-1660; enrollment in dose escalation and backfill cohorts continuing in parallel; expect to announce initial clinical data and initiate expansion in the second half of 2024 Patient recruitment ongoing in Phase 1 cl...
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that ...
2024-03-18 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...